Esperion Therapeutics
ESPR
#7606
Rank
โ‚น25.37 B
Marketcap
โ‚น123.15
Share price
-4.00%
Change (1 day)
-47.05%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น62.64 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚น62.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น62.84 B14.24%
2023-12-31โ‚น55.01 B16.28%
2022-12-31โ‚น47.30 B9.87%
2021-12-31โ‚น43.06 B31.02%
2020-12-31โ‚น32.86 B136.96%
2019-12-31โ‚น13.86 B208.33%
2018-12-31โ‚น4.49 B112.56%
2017-12-31โ‚น2.11 B87.48%
2016-12-31โ‚น1.12 B104.33%
2015-12-31โ‚น0.55 B-10.34%
2014-12-31โ‚น0.61 B137.29%
2013-12-31โ‚น0.25 B-80.8%
2012-12-31โ‚น1.35 B210.41%
2011-12-31โ‚น0.43 B
2002-12-31โ‚น0.60 B6.28%
2001-12-31โ‚น0.57 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น106.14 B 69.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น113.82 B 81.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.681 T 16,950.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น718.84 B 1,047.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.54 B-19.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.03 B-79.19%๐Ÿ‡บ๐Ÿ‡ธ USA